Literature DB >> 13883604

Epidemiology of uveitis. Incidence and prevalence in a small urban community.

R W DARRELL, H P WAGENER, L T KURLAND.   

Abstract

Entities:  

Keywords:  UVEITIS/statistics

Mesh：

Year:  1962        PMID： 13883604     DOI： 10.1001/archopht.1962.00960030506014

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  85 in total

Review 1.  Anterior uveitis: clinical and research perspectives.

Authors:  J T Rosenbaum; T M Martin; S R Planck
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Risk of Noninfectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database.

Authors:  Lucia Sobrin; Yinxi Yu; Gayatri Susarla; Weilin Chan; Tian Xia; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Ophthalmology       Date:  2020-04-27       Impact factor: 12.079

Review 3.  Management of sight-threatening uveitis: new therapeutic options.

Authors:  Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.

Authors:  Andrew W Taylor; Henry J Kaplan
Journal:  Ocul Immunol Inflamm       Date:  2010-12       Impact factor: 3.070

Review 5.  The possible impact of uveitis in blindness: a literature survey.

Authors:  M S Suttorp-Schulten; A Rothova
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

6.  Tissue-specific production of MicroRNA-155 inhibits melanocortin 5 receptor-dependent suppressor macrophages to promote experimental autoimmune uveitis.

Authors:  Fauziyya Muhammad; Anna Trivett; Dawei Wang; Darren J Lee
Journal:  Eur J Immunol       Date:  2019-06-19       Impact factor: 5.532

Review 7.  The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

Authors:  Melissa A Lerman; C Egla Rabinovich
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

8.  Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Authors:  John H Kempen; Mark L Van Natta; Michael M Altaweel; James P Dunn; Douglas A Jabs; Susan L Lightman; Jennifer E Thorne; Janet T Holbrook
Journal:  Am J Ophthalmol       Date:  2015-09-18       Impact factor: 5.258

9.  Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital.

Authors:  R L Smit; G S Baarsma; J de Vries
Journal:  Int Ophthalmol       Date:  1993-04       Impact factor: 2.031

10.  Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist.

Authors:  Ming-Ling Tsai; Chi-Ting Horng; Show-Li Chen; Xiao Xiao; Chih-Hung Wang; Yeou-Ping Tsao
Journal:  Mol Vis       Date:  2009-08-08       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.